Psyence and Eden Labs extraction and product development collaboration
January 25, 2023 By Grow Opportunity Staff
(Globe Newswire) Toronto – Psyence Group Inc., a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, has entered into a partnership with Eden Labs LLC, a product development and extraction technology company that has developed intellectual property and methodologies around the extraction of psilocybin-yielding mushrooms.
The partnership features a Global IP Licensing Agreement for the commercialization by Psyence of extraction technology and formulation IP developed by Eden Labs for the production of a water soluble, doseable, stabilized psilocybin powder naturally derived from the fruiting bodies of psilocybin-yielding mushrooms cultivated and processed at Psyence’s federally licensed certified facility in Southern Africa.
Psyence is also pleased to be appointing AC Braddock, CEO of Eden Labs, to its scientific advisory board to utilize her skill sets in methodology and product development. AC has earned global recognition for her visionary leadership in strategic industry building, political engagement, board leadership, organizational health, extraction technology, natural products formulations, product placement, branding from problem solving and as an inspirational speaker.
The partnership will be facilitated by South African entrepreneur Cody Futeran who will play an active role in the business development arm of the venture.
“Psyence is extremely excited to be entering into a relationship with Eden Labs who, for 27 years, has advanced product development through green extraction technology in the health and wellness sectors. Our ongoing collaboration in the production of plant medicines for clinical protocols will significantly expand our ability to bring valuable medical resources to the application of psychedelic research worldwide” – Dr. Neil Maresky, Psyence Chief Executive Officer
Print this page